Gold’s lustre may fade

published 5 January 2018

Gold was overshadowed by equities and base metals in 2017, with the latter climbing by 25%. Yet the yellow metal still rose by around a tenth. This year, however, it may not fare so well.

Gold thrives on bad news, but the world economy has finally shaken off its post-bubble hangover and is starting to motor. As growth rises towards its pre-crisis highs in both emerging and developed markets, investments traditionally considered safe havens will struggle. Gold has no yield, so rising interest rates, especially in the US, dent its relative appeal.

The bitcoin buzz isn't helping: cryptocurrencies, like gold, are a medium of exchange that can't be endlessly reproduced, and thus debased, in the way that paper currencies can.It is telling that late last year the number of Google searches for "buy bitcoin" overtook those for "buy gold" for the first time, as Bloomberg points out.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Nonetheless, keep 5%-10% of your portfolio in gold. Several geopolitical flashpoints could frighten investors, while inflation could make an unexpectedly strong return if wage growth finally takes off in America and Britain reminding markets that gold has been a store of value for centuries.

Andrew is the editor of MoneyWeek magazine. He grew up in Vienna and studied at the University of St Andrews, where he gained a first-class MA in geography & international relations.

After graduating he began to contribute to the foreign page of The Week and soon afterwards joined MoneyWeek at its inception in October 2000. He helped Merryn Somerset Webb establish it as Britain’s best-selling financial magazine, contributing to every section of the publication and specialising in macroeconomics and stockmarkets, before going part-time.

His freelance projects have included a 2009 relaunch of The Pharma Letter, where he covered corporate news and political developments in the German pharmaceuticals market for two years, and a multiyear stint as deputy editor of the Barclays account at Redwood, a marketing agency.

Andrew has been editing MoneyWeek since 2018, and continues to specialise in investment and news in German-speaking countries owing to his fluent command of the language.